Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Psychemedics (PMD)

Psychemedics (PMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,356
  • Shares Outstanding, K 5,806
  • Annual Sales, $ 22,100 K
  • Annual Income, $ -4,150 K
  • 60-Month Beta 0.64
  • Price/Sales 0.68
  • Price/Cash Flow N/A
  • Price/Book 2.31
Trade PMD with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/14
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.16
  • Growth Rate Est. (year over year) +624,275.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.51 +5.38%
on 04/19/24
3.07 -13.96%
on 03/26/24
-0.32 (-10.64%)
since 03/22/24
3-Month
2.51 +5.38%
on 04/19/24
3.48 -23.99%
on 01/30/24
-0.68 (-20.57%)
since 01/24/24
52-Week
2.06 +28.40%
on 11/21/23
5.59 -52.69%
on 05/01/23
-2.76 (-51.02%)
since 04/24/23

Most Recent Stories

More News
Psychemedics: Q3 Earnings Snapshot

Psychemedics: Q3 Earnings Snapshot

PMD : 2.64 (+2.27%)
Psychemedics: Q2 Earnings Snapshot

Psychemedics: Q2 Earnings Snapshot

PMD : 2.64 (+2.27%)
Psychemedics: Q1 Earnings Snapshot

Psychemedics: Q1 Earnings Snapshot

PMD : 2.64 (+2.27%)
Psychemedics: Q4 Earnings Snapshot

Psychemedics: Q4 Earnings Snapshot

PMD : 2.64 (+2.27%)
Psychemedics: Q3 Earnings Snapshot

Psychemedics: Q3 Earnings Snapshot

PMD : 2.64 (+2.27%)
Psychemedics Corporation Reports Second Quarter 2022 Financial Results and Declares Quarterly Cash Dividend

ACTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse,...

PMD : 2.64 (+2.27%)
Psychemedics Announces Two New Director Nominees for its 2022 Annual Meeting of Stockholders and Director Walter S. Tomenson, Jr.’s Retirement after More than 20 Years of Dedicated Service

ACTON, Mass., June 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced today that it will be nominating Peter H. Kamin and...

PMD : 2.64 (+2.27%)
Psychemedics Corporation Reports First Quarter 2022 Financial Results and Declares Increased Cash Dividend

ACTON, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse,...

PMD : 2.64 (+2.27%)
Psychemedics Corporation Reports Fourth Quarter and Full Year 2021 Financial Results

ACTON, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse,...

PMD : 2.64 (+2.27%)
Psychemedics Corporation Welcomes Drew Reynolds to Its Board of Directors and Announces the Retirement of Harry Connick From His Director Role

ACTON, Mass., March 22, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world’s largest provider of hair testing for drugs of abuse,...

PMD : 2.64 (+2.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.

See More

Key Turning Points

3rd Resistance Point 2.72
2nd Resistance Point 2.71
1st Resistance Point 2.67
Last Price 2.64
1st Support Level 2.63
2nd Support Level 2.62
3rd Support Level 2.58

See More

52-Week High 5.59
Fibonacci 61.8% 4.24
Fibonacci 50% 3.83
Fibonacci 38.2% 3.41
Last Price 2.64
52-Week Low 2.06

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar